Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Reichmann

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Nuklearmedizin. Nuclear Medicine|September 12, 2006
Therapy of hepatocellular carcinoma with iodine-131-lipiodol. Results in a large German cohortJ H Risse, C Rabe, D Pauleit, et al.
Nuklearmedizin. Nuclear Medicine|August 1, 1986
A comparative study of the brain uptake and early kinetics of 99mTc-dl HM-PAO and other PnAO derivatives in baboonsK Reichmann, H J Biersack, L Basso, et al.
Nuclear Medicine Review. Central & Eastern Europe|November 6, 2003
rCBF SPECT and the acetazolamide test in the evaluation of dementiaL Pávics, F Grünwald, K Reichmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1987
Technetium-99m HM-PAO brain SPECT in epileptic patients before and during unilateral hemispheric anesthesia (Wada test): report of three casesH J Biersack, D Linke, F Brassel, et al.
Nuklearmedizin. Nuclear Medicine|October 10, 2013
Residual activity after radioembolization of liver tumours with 90Y resin microspheres. A safe calculation methodH Ahmadzadehfar, T Haslerud, K Reichmann, et al.
Deutsche Medizinische Wochenschrift (1946)|February 12, 1988
[Nuclear medicine diagnosis of Alzheimer type dementia]F Grünwald, K Broich, A Hartmann, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 1988
[HMPAO-SPECT in cerebral seizures]F Grünwald, H Durwen, P Bülau, et al.
Nuklearmedizin. Nuclear Medicine|October 17, 2007
Therapy of hepatocellular carcinoma with 131I-lipiodol: patient dosimetryJ H Risse, D Pauleit, H Palmedo, et al.
Nuklearmedizin. Nuclear Medicine|August 22, 2013
Early prediction of tumour response to PRRT. The sequential change of tumour-absorbed doses during treatment with 177Lu-octreotateS Ezziddin, K Reichmann, C Yong-Hing, et al.
Neurochirurgia|May 1, 1988
[Preoperative diagnosis: the Wada test with SPECT control for localizing brain function in therapy-refractory epilepsy]M Kurthen, H J Biersack, D B Linke, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Nuklearmedizin. Nuclear Medicine|September 12, 2006
Therapy of hepatocellular carcinoma with iodine-131-lipiodol. Results in a large German cohortJ H Risse, C Rabe, D Pauleit, et al.
Nuklearmedizin. Nuclear Medicine|August 1, 1986
A comparative study of the brain uptake and early kinetics of 99mTc-dl HM-PAO and other PnAO derivatives in baboonsK Reichmann, H J Biersack, L Basso, et al.
Nuclear Medicine Review. Central & Eastern Europe|November 6, 2003
rCBF SPECT and the acetazolamide test in the evaluation of dementiaL Pávics, F Grünwald, K Reichmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1987
Technetium-99m HM-PAO brain SPECT in epileptic patients before and during unilateral hemispheric anesthesia (Wada test): report of three casesH J Biersack, D Linke, F Brassel, et al.
Nuklearmedizin. Nuclear Medicine|October 10, 2013
Residual activity after radioembolization of liver tumours with 90Y resin microspheres. A safe calculation methodH Ahmadzadehfar, T Haslerud, K Reichmann, et al.
Deutsche Medizinische Wochenschrift (1946)|February 12, 1988
[Nuclear medicine diagnosis of Alzheimer type dementia]F Grünwald, K Broich, A Hartmann, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 1988
[HMPAO-SPECT in cerebral seizures]F Grünwald, H Durwen, P Bülau, et al.
Nuklearmedizin. Nuclear Medicine|October 17, 2007
Therapy of hepatocellular carcinoma with 131I-lipiodol: patient dosimetryJ H Risse, D Pauleit, H Palmedo, et al.
Nuklearmedizin. Nuclear Medicine|August 22, 2013
Early prediction of tumour response to PRRT. The sequential change of tumour-absorbed doses during treatment with 177Lu-octreotateS Ezziddin, K Reichmann, C Yong-Hing, et al.
Neurochirurgia|May 1, 1988
[Preoperative diagnosis: the Wada test with SPECT control for localizing brain function in therapy-refractory epilepsy]M Kurthen, H J Biersack, D B Linke, et al.
Pageof 5